Citius Pharmaceuticals
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2007-01-01
- Employees
- 22
- Market Cap
- $106.9M
- Website
- http://www.citiuspharma.com
- Introduction
Citius Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of critical care products, with a focus on oncology, anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. Its products include I/ONTAK, Mino-Lok, Halo-Lido, Mino-Wrap, and Novecite. The company was founded by Ralph Montrone on January 23, 2007 and is headquartered in Cranford, NJ.
Safety and Efficacy of CITI-002 in Adult Patients With Moderate Grade Hemorrhoids
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2022-04-27
- Last Posted Date
- 2023-08-31
- Lead Sponsor
- Citius Pharmaceuticals, Inc.
- Target Recruit Count
- 304
- Registration Number
- NCT05348200
- Locations
- 🇺🇸
Site #12, Prairieville, Louisiana, United States
🇺🇸Site #11, Mentor, Ohio, United States
🇺🇸Site #04, Harrisburg, Pennsylvania, United States
Safety and Efficacy of Hydrocortisone and Lidocaine Treatment of Grade I and II Hemorrhoids
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-02-24
- Last Posted Date
- 2016-02-24
- Lead Sponsor
- Citius Pharmaceuticals, Inc.
- Target Recruit Count
- 211
- Registration Number
- NCT02689856
© Copyright 2024. All Rights Reserved by MedPath